Preparation and administration

Cryoprecipitate is prepared from fresh frozen plasma by slow controlled thawing at 4 to 6 °C. The resulting precipitate is separated from the supernatant and refrozen for storage. Cryoprecipitate contains factor VIII, von Willebrand factor, fibrinogen, factor XIII, and fibronectin in higher concentrations than is found in fresh frozen plasma. For these reasons it used to be the mainstay of treatment for hemophilia A and von Willebrand's disease, but it has been superseded by virally inactivated pooled factor concentrates. The same guidelines as for administration of fresh frozen plasma apply for cryoprecipitate and it carries a similar risk of transmission of infection. The dose for one transfusion is 10 to 30 units depending on the circumstances.

Kicking Fear And Anxiety To The Curb

Kicking Fear And Anxiety To The Curb

Kicking Fear And Anxiety To The Curb Can Have Amazing Benefits For Your Life And Success. Learn About Calming Down And Gain Power By Learning Ways To Become Peaceful And Create Amazing Results.

Get My Free Ebook

Post a comment